Holden Thorp

Director at PIPr Therapeutics.

Earliest Form D on file: Nov 2025

Filed Nov 12, 2025

PIPr Therapeutics

Preclinical metalloprotease inhibitor drugs

Biotech, Durham NC

Named, Director.

$1.5M

sold of $2.5M offered

Network

At PIPr Therapeutics

2 people

Heather Madsen
Executive Officer, Director
Clay Thorp
Director